The wrong time to hire with David Park, Narada
TL;DR
Narada CEO David Park shares how his enterprise AI startup achieved 99.99% automation reliability and product-market fit through nearly 1,000 customer conversations before raising VC funding, arguing that excess capital too early removes the friction necessary for building truly customer-centric products.
🏭 Enterprise AI That Actually Works 3 insights
Large Action Models achieve 99.99% reliability
Unlike general AI models that deliver 60-80% accuracy, Narada's UC Berkeley research-based system provides the consistency required for healthcare and financial enterprise workflows.
Agentic automation without backend integration
The platform visually reasons about screen elements to execute complex multi-step processes like 'hire to retire' by mimicking human clicks and scrolling, eliminating the need for API connections or code changes.
Zero data retention with on-prem options
Narada stores no customer data and offers fully air-gapped deployments for security-conscious financial and insurance companies.
🎯 Finding Product-Market Fit 3 insights
The 'open wallets' validation test
Park emphasizes that polite feedback is meaningless; real product-market fit is proven only when customers actually pay money, as people won't tell you your 'baby is ugly.'
1,000 customer conversations before fundraising
The team spent over a year conducting nearly a thousand customer calls to identify last-mile problems and high-value use cases before raising institutional capital.
Natural language enables horizontal adaptability
Users describe workflows in English or demonstrate them manually, allowing the system to adapt to niche enterprise variations without hardcoded configurations that constantly break.
💰 Capital-Efficient Growth Strategy 3 insights
Bootstrap until unit economics prove out
Park avoided premature VC scaling because excess capital removes the friction that forces customer-centricity; they raised only after demonstrating $10 return per $1 invested.
Validate investors through contribution
Lead investor Bang Shukla from Monavista Capital provided months of customer introductions and strategic advice before Narada accepted his funding, ensuring proven value before joining the cap table.
Build a lean 'building machine' first
Drawing from his first company, Park advocates staying 'poor and hungry' to maintain focus on revenue-generating features rather than burning cash on premature hiring or scale.
Bottom Line
Founders should bootstrap through intensive customer discovery until achieving product-market fit validated by paying customers, only then raising capital from investors who have already proven their strategic value through advice and introductions.
More from TechCrunch
View all
Everyone wants a piece of the enterprise AI pie | Equity Podcast
The podcast explores XAI's pivot from AI lab to GPU landlord through a major compute deal with Anthropic, a resurgence in crypto venture funding driven by regulatory shifts, and the viral crowdfunding attempt to save bankrupt Spirit Airlines.
The long road to driverless with Aurora's Chris Urmson (Live at HumanX) | Equity Podcast
Aurora CEO Chris Urmson explains why autonomous trucking has reached an inflection point, moving from pilot programs to commercial scale operations across the Sun Belt with over 250,000 driverless miles completed. With next-generation hardware unlocking production of thousands of vehicles and California regulations expected to ease, Aurora is betting that freight economics and 24/7 utilization advantages will drive adoption faster than robotaxis.
Musk v. Altman is just getting started | Equity Podcast
This episode examines the legal fallout when Sallie Mae allegedly monetized Scoly's student data post-acquisition despite founder promises, BMW i Ventures' $300 million strategic bet on industrial AI automation, and how Scout AI's $100 million raise signals defense tech's mainstream acceptance.
Keeping Your Team Motivated When FDA Approval Isn’t Guaranteed l Build Mode
Biotics AI CEO Robbie Bustami shares strategies for navigating FDA clearance for their AI ultrasound co-pilot, emphasizing early regulatory engagement, integrating clinical studies with go-to-market plans, and maintaining team motivation through multi-year approval timelines.